Navigation Links
Taglich Brothers Initiates Coverage on FluroPharma Medical, Inc.
Date:4/25/2013

New York, NY (PRWEB) April 25, 2013

FluoroPharma Medical, Inc. announces Taglich Brothers has initiated coverage.

FluoroPharma Medical, Inc.(FPMI: OTC BB), headquartered in Montclair, New Jersey, is a development stage enterprise founded in 2003 to develop pharmaceuticals based on technology licensed exclusively from the University of Massachusetts.

FPMI is focused on the development of radiopharmaceuticals used in positron emission tomography (PET) imaging scans that can more effectively detect and evaluate acute and chronic forms of coronary artery disease (CAD). Nuclear imaging scans are more effective diagnostic tools, as they can show changes in the function of an organ indicating disease or its progression more efficiently than the static images produced by conventional imaging modalities.

FluoroPharma Medical’s currently has three drug candidates. BFPET™ detects damaged tissue by measuring blood flow through the heart. CardioPET™ detects damaged heart tissue in CAD or suspected CAD patients unable to undergo conventional (exercise) stress tests. CardioPET is also useful in cardiac viability assessment (CVA) of patients prior to or after revascularization. BFPET and CardioPET are now in phase II trials. VasoPET™, still in preclinical development, aims to detect coronary artery plaque that is liable to break loose and lead to formation of clots that cause oxygen deprivation in the heart muscle, potentially causing a heart attack or stroke.

The complete 21-page report is available at http://www.taglichbrothers.com.

We do not undertake
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. PLC Medical Systems To Present At Taglich Brothers 10th Annual Small Cap Equity Conference
2. Derma Sciences To Present At Taglich Brothers 10th Annual Small Cap Equity Conference
3. Fluoropharma Medical To Present At Taglich Brothers 10th Annual Small Cap Equity Conference
4. Aeolus Pharmaceuticals To Present At Taglich Brothers 10th Annual Small Cap Equity Conference
5. South Charlotte Dentistry Initiates New Emphasis on Comprehensive Dental Treatment
6. UK initiates first cancer reporting model of its kind in US
7. Study finds newspapers have changed coverage of ice hockey concussions over last quarter-century
8. WINFertility Treatment Program Expands to Central/Southern Texas. Program Makes IVF Treatment More Affordable for Patients Without Infertility Insurance Coverage.
9. News Coverage of Shootings May Boost Stigma of Mental Illness
10. Media coverage of mass shootings contributes to negative attitudes towards mental illness
11. New Englanders Without IVF Coverage Have a More Affordable Way to Seek Help Through the WINFertility® Treatment Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014 Living in a quality ... that comes along with it. A quality Home Owners ... such amenities are available. , Simpson ... Georgia and Community Association Management, LLC made a recent ... Company to provide an additional amenity for their neighborhood. ...
(Date:8/21/2014)... arteries of chronic kidney disease patients may be a ... new study in the Journal of the American ... the Johns Hopkins Bloomberg School of Public Health assert ... of subclinical atherosclerosis in predicting the risk of heart ... percent of all patients with chronic kidney disease (CKD) ...
(Date:8/21/2014)... Dallas, TX (PRWEB) August 21, 2014 ... August 20 entertained residents with dementia at Silverado Turtle ... Improv Troupe, which consists of entertainers ranging from ages ... each time they perform their 40-minute set. The troupe's ... makes it universal and allows them to touch audiences ...
(Date:8/21/2014)... August 21, 2014 The City of ... for entertainment and programming for its inaugural “Re:Imagine Garden ... October 12, 2014, from 11 a.m. to 4 p.m., ... all cars and the downtown will be filled with ... by Community Arts Resources (CARS), for all to enjoy. ...
(Date:8/21/2014)... Among seniors, dimming vision may be tied to poorer survival, ... people, aged 65 to 84, who were assessed when they ... years later. Vision loss over time was associated with ... study period, the researchers reported. Although the study couldn,t ... Purdue University in West Lafayette, Ind., offered up some theories ...
Breaking Medicine News(10 mins):Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 3Health News:Measuring calcium buildup to predict heart disease in those with chronic kidney disease 2Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 3Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 4Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2
... new study by Ohio State University researchers has shown ... are not being managed appropriately.,The researchers who looked at ... patients' own descriptions of anxiety after a heart attack ... doctors do not match. In the group of,participants it ...
... been found for detecting upper urinary tract transitional cell ... Canada. This method checks for fibrinogen/fibrin degradation products. It ... to standard urinary cytology. The Researchers compared the efficacy ... cytology in establishing the diagnosis// of transitional cell carcinoma ...
... came up in 1971 argued that people react to ... eventually return to a stable level of well-being. Researchers ... France and England confirmed this theory based on a ... on life satisfaction. 24,000 individuals were followed for 15 ...
... first of its kind study compared a group of whiplash patients ... who suffered a whiplash injury had pain in the neck, head, ... a year. In the study of the two groups, pain in ... a month while in the whiplash injury group patients were still ...
... Examination Survey has now uncovered a link between Periodontal ... of gum disease that causes infection and inflammation of ... of the study where divided into two groups, depending ... an indicator of the presence of periodontal disease. They ...
... Live cancer is one of the most aggressive cancers worldwide ... countries due to hepatitis infection and aflatoxin contamination of foodstuffs. ... Researchers in the US and China have been studying gene ... and found a way of detecting tumors that spread. They ...
Cached Medicine News:
(Date:8/21/2014)... 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ), ... that it has completed integration with Nextech, a ... Surgery and Dermatology practices. "Integration allows ... healthcare practices using Nextech," stated Bob Fabbio ... information from the EMR we are able to ...
(Date:8/21/2014)... 2014  Decision Resources Group finds that, for ... Brazil and Mexico ... prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist ... current severe cost/coverage constraints. Therefore, new brands of ... launch in these countries—which will considerably expand the ...
(Date:8/21/2014)...  Zacks.com announces the list of stocks featured in the ... the latest news and events impacting stocks and the financial ... HPQ - Free Report ), IBM (NYSE: IBM ... - Free Report ), GlaxoSmithKline plc (NYSE: GSK - ... - Free Report ). Today, Zacks is promoting ...
Breaking Medicine Technology:eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11
... Inc., a privately-held developer and marketer of the VerifyNow ... for measuring platelet reactivity to multiple antiplatelet agents, announced ... Portola Pharmaceuticals, Inc. to develop and supply the VerifyNow ... The VerifyNow System is widely used by practicing ...
... SUNNYVALE, Calif., March 2, 2011 Pharmacyclics, Inc. (Nasdaq: ... of PCI-45292, a Btk inhibitor with exceptionally potent anti-arthritis ... results from the current set of preclinical toxicology studies. ... candidate identified within approximately 6 months. ...
Cached Medicine Technology:Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc. 2Update on Preclinical Finding and Development Timeline for PCI-45292 2Update on Preclinical Finding and Development Timeline for PCI-45292 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 7.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 9 mm....
Medicine Products: